Clinical Trials Browser

Uterine Neoplasms × fosaprepitant × Gynecologic × Clear all

NCT01432015 2017-03-28

Fosaprepitant Versus Aprepitant in the Prevention of Chemotherapy Induced Nausea and Vomiting

Phase 4 Completed

20 enrolled 5 charts

Ovarian Neoplasms, Uterine Neoplasms, Vomiting